Review article · 2022 · Open access
Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium
Medicina, 58(1), 121 · Published 13 January 2022 · DOI 10.3390/medicina58010121
In brief
“Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium” is a 2022 review article by Hong Guo Parke and 4 co-authors, published in Medicina. OpenAlex counts 24 citations as of 21 November 2026, which puts it in the top 6% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Medicina.
- Citations
- 24
- Most cited in
- 2026 (9)
- Field-weighted impact
- 0.35
- References
- 154
- Authors
- 5
Abstract
COPD is a chronic lung disorder characterized by a progressive and irreversible airflow obstruction, and persistent pulmonary inflammation. It has become a global epidemic affecting 10% of the population, and is the third leading cause of death worldwide. Respiratory viruses are a primary cause of COPD exacerbations, often leading to secondary bacterial infections in the lower respiratory tract. COPD patients are more susceptible to viral infections and associated severe disease, leading to accelerated lung function deterioration, hospitalization, and an increased risk of mortality. The airway epithelium plays an essential role in maintaining immune homeostasis, and orchestrates the innate and adaptive responses of the lung against inhaled and pathogen insults. A healthy airway epithelium acts as the first line of host defense by maintaining barrier integrity and the mucociliary escalator, secreting an array of inflammatory mediators, and initiating an antiviral state through the interferon (IFN) response. The airway epithelium is a major site of viral infection, and the interaction between respiratory viruses and airway epithelial cells activates host defense mechanisms, resulting in rapid virus clearance. As such, the production of IFNs and the activation of IFN signaling cascades directly contributes to host defense against viral infections and subsequent innate and adaptive immunity. However, the COPD airway epithelium exhibits an altered antiviral response, leading to enhanced susceptibility to severe disease and impaired IFN signaling. Despite decades of research, there is no effective antiviral therapy for COPD patients. Herein, we review current insights into understanding the mechanisms of viral evasion and host IFN antiviral defense signaling impairment in COPD airway epithelium. Understanding how antiviral mechanisms operate in COPD exacerbations will facilitate the discovery of potential therapeutic interventions to reduce COPD hospitalization and disease severity.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Parke, H. G., Linden, D. A., Weldon, S., Kidney, J. C., & Taggart, C. C. (2022). Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium. Medicina, 58(1), 121. https://doi.org/10.3390/medicina58010121
MLA 9
Parke, Hong Guo, et al. “Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium.” Medicina, vol. 58, no. 1, 2022, p. 121. https://doi.org/10.3390/medicina58010121.
Chicago
Parke, Hong Guo, Dermot A. Linden, Sinéad Weldon, Joseph C. Kidney, and Clifford C. Taggart. 2022. “Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium.” Medicina 58 (1): 121. https://doi.org/10.3390/medicina58010121.
Harvard
Parke, H. G. et al. (2022) ‘Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium’, Medicina, 58(1), p. 121. doi:10.3390/medicina58010121.
IEEE
H. G. Parke, D. A. Linden, S. Weldon, J. C. Kidney, and C. C. Taggart, “Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium,” Medicina, vol. 58, no. 1, p. 121, 2022, doi: 10.3390/medicina58010121.
BibTeX
@article{parke2022deciphering,
title = {{Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium}},
author = {Parke, Hong Guo and Linden, Dermot A. and Weldon, Sinéad and Kidney, Joseph C. and Taggart, Clifford C.},
journal = {Medicina},
year = {2022},
volume = {58},
number = {1},
pages = {121},
doi = {10.3390/medicina58010121},
url = {https://doi.org/10.3390/medicina58010121}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 3 | |
| 2023 | 3 | |
| 2024 | 4 | |
| 2025 | 5 | |
| 2026 | 9 |
Its field-weighted citation impact is 0.35: it has been cited 0.35 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- chronic obstructive pulmonary disease
- respiratory viruses
- interferon signaling
- airway epithelium
- COPD exacerbations
- antiviral defense
- viral evasion
- innate immunity
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Parke, H. G., Linden, D. A., Weldon, S., Kidney, J. C., & Taggart, C. C. (2022). Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium. Medicina, 58(1), 121. https://doi.org/10.3390/medicina58010121
How many times has this paper been cited?
24 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Medicina: sign in and open the PDF from this page.
Who wrote this paper?
Hong Guo Parke, Dermot A. Linden, Sinéad Weldon, Joseph C. Kidney, Clifford C. Taggart.
What is the DOI of this paper?
10.3390/medicina58010121, permanently at https://doi.org/10.3390/medicina58010121. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.